In the current study, low expression of PDS5B was observed and correlated with lymph node metastasis in lung cancer patients, indicating that PDS5B might be associated with the prognosis of lung cancer patients. This evidence concerns the gene PDS5B and metastatic malignant neoplasm in the lymph nodes.